Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis

Leading NF Advocacy
Building NF Community

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis

Author: Scott R. Plotkin, MD, PhD, Massachusetts General Hospital

Published On: 8//3/26

This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of investigational drugs to learn whether the drug(s) works in treating a specific disease. As a basket study, the trial will enroll patients with NF2-SWN with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas.

Find upcoming NF Events Donate to NF Stay iNFormed

Want to view archived newsletters? Click Here!

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis

Author: Scott R. Plotkin, MD, PhD, Massachusetts General Hospital

Published On: 8//3/26

Newsletter

Categories

Have a story you'd like to share with the NF community? Click Here!